Not currently recruiting at University of California Health
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Summary
- Eligibility
- for people ages 6 months to 35 months (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Encoded Therapeutics
- ID
- NCT05419492
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 22 study participants
- Last Updated